Clinical Trials Browser

Terminated × INDUSTRY × icaritin × Clear all

NCT03236649 2023-02-08

The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular